Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Qi Yuan
Huazhong University of Science and Technology - Department of Pharmacy
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
65
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
The Safety and Economic Evaluation of Bevacizumab and PD-1 Inhibitors for Advanced Non-Squamous NSCLC: A Multicenter Observational Study in China
Number of pages: 18
Posted: 15 May 2024
Min Hu
,
Changdong Diao
,
Jinmei Liu
,
Xiong Wang
, Qi Yuan,
Shijun Li
,
Guojie Di
,
hongqin ke
,
Ge Zhang
,
Zhuoran Xu
,
Chaoxuan Lou
,
Yanli Xue
,
Yu Zhang
and
Chen Shi
Huazhong University of Science and Technology - Department of Pharmacy, Huazhong University of Science and Technology - Department of Pharmacy, Huazhong University of Science and Technology - Department of Pharmacy, Huazhong University of Science and Technology - Department of Pharmacy, Huazhong University of Science and Technology - Department of Pharmacy, Huazhong University of Science and Technology - Department of Pharmacy, Shandong University - Liaocheng People's Hospital, Hubei University of Medicine - Taihe Hospital, Nankai University - Tianjin First Central Hospital, Henan Provincial People's Hospital, Henan University of Science and Technology - College of Clinical Medicine, Henan University of Science and Technology - College of Clinical Medicine, Huazhong University of Science and Technology - Department of Pharmacy and Huazhong University of Science and Technology - Department of Pharmacy
Downloads
65
(916,100)
View PDF
Download
Abstract:
bevacizumab, safety, economic evaluation, PD-1 inhibitors, advanced non-squamous NSCLC
Feedback